Effects of first-line diabetes therapy with biguanides, sulphonylurea and thiazolidinediones on the differentiation, proliferation and apoptosis of islet cell populations

AIMS: Metformin, rosiglitazone and sulfonylureas enhance either insulin action or secretion and thus have been used extensively as early stage anti-diabetic medication, independently of the aetiology of the disease. When administered to newly diagnosed diabetes patients, these drugs produce variable...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarnobat, D., Moffett, R. C., Flatt, P. R., Tarasov, A. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741670/
https://www.ncbi.nlm.nih.gov/pubmed/34191257
http://dx.doi.org/10.1007/s40618-021-01620-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741670/
https://www.ncbi.nlm.nih.gov/pubmed/34191257
http://dx.doi.org/10.1007/s40618-021-01620-6

Ejemplares similares